Hints and tips:
Related Special Reports
...The S&P biotech index is trading about 50 per cent below its peak in February 2021....
...London’s unfancied FTSE 100 index, which rose just 3.8 per cent this year against a 24 per cent jump in Wall Street’s S&P 500, was also home to high-street mainstay Marks and Spencer, which took the third...
...The stock bucked the wider pharma sell-off, rising 60 per cent last year. A price to forward earnings multiple of over 50 values the stock more like a tech company than a pharma group....
...The Granolas as a group have climbed 18 per cent over the past 12 months beating the Stoxx 600’s 7.5 per cent rise over the same period....
...The new generation of diet drugs are one of the top trends on calls this year, going well beyond pharma/biotechs....
...The US pharmaceutical company — whose shares are up 130 per cent over the past year and is now a top-10 S&P 500 stock — chose the week of the Oscars to launch an advert called “Big Night”....
...German pharma group Boehringer Ingelheim and Copenhagen-based Zealand Pharma said their weight-loss drug had achieved positive results in liver disease trials....
...A once-popular fund, the SPDR S&P Biotech ETF, has lost 14 per cent of its value this year, falling 60 per cent from its highs....
...Just over a decade later I was bemoaning the Götterdämmerung of Big Pharma in the Lombard column....
...High-grade pharma group Bristol Myers Squibb sold $13bn of debt on Wednesday....
...Novo Nordisk’’s share price closed up 0.7 per cent to DKK1,311 ($190), giving the company a market capitalisation of $428bn. On Friday last week it had briefly dethroned LVMH....
...Coates also narrowly trumps the best-paid executives in the US S&P 500, where Blackstone’s Stephen Schwarzman earned $253mn last year (he separately received about $1bn in dividends) and Alphabet’s Sundar...
...In a quieter deal environment, this deal underscores that Big Pharma has the means to make big bets....
...Monday Camillo Pane becomes Alliance Pharma chair, succeeding Jo LeCouilliard China: stock exchanges reopen after Chinese Lunar New Year holiday Germany: Buba Monthly Report Sweden: January consumer...
...It is not a stretch for Sanofi, with a net debt-to-ebitda ratio of 0.6 according to S&P Capital IQ....
...Some investors fear that the uncertainty over Roundup’s financial burden could limit Anderson’s room for manoeuvre with regard to a potential separation of Bayer’s crop science business and its pharma unit...
...It follows Channel 4’s announcement of 200 job cuts, with staff reductions also soon likely at the BBC and ITV. Wuhan in China is emerging as a key testing centre for self-driving cars....
...Oxford’s partnership with the Serum Institute of India, the world’s largest vaccine maker by doses, gives it much bigger production capacity than pharma group GSK has for its RTS,S shot, the first malaria...
...The company subsequently grew by acquiring other companies and counts Platts, part of credit rating company S&P, among its competitors....
...AstraZeneca is the jewel in the FTSE 100’s crown. The pharmaceutical group now has a market capitalisation of £182bn....
...In Japan, as long ago as 1996, a financial settlement was reached with the victims; the head of one of the pharma companies involved made a televised act of contrition....
...The same complaints can be heard across the innovation industries, including medtech and pharma....
...The Second Circuit’s decision to clear the way for Purdue Pharma’s settlement to move forward is a rightful win for the court of equity over the court of public opinion (Report, May 31.)...
...Blue blood of horseshoe crabs puts pharma groups under scrutiny....
...Last week, rating agency S&P upgraded the country’s debt to investment grade....
International Edition